购物车
全部删除
您的购物车当前为空
HSD17B13-IN-64 (Compound 143) 作为一种羟基类固醇 17β-脱氢酶 13 (HSD17B13) 抑制剂,显示出对雌二醇的高效抑制作用,其IC50值 ≤ 0.1 μM。此化合物主要应用于研究肝病、代谢性疾病或心血管疾病,包括NAFLD、NASH及药物性肝损伤 (DILI)。

HSD17B13-IN-64 (Compound 143) 作为一种羟基类固醇 17β-脱氢酶 13 (HSD17B13) 抑制剂,显示出对雌二醇的高效抑制作用,其IC50值 ≤ 0.1 μM。此化合物主要应用于研究肝病、代谢性疾病或心血管疾病,包括NAFLD、NASH及药物性肝损伤 (DILI)。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 10,600 | 6-8周 | |
| 50 mg | ¥ 13,800 | 6-8周 | |
| 100 mg | ¥ 17,500 | 6-8周 |
HSD17B13-IN-64 相关产品
| 产品描述 | HSD17B13-IN-64 (Compound 143), an inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), exhibits a potent IC50 value of ≤ 0.1 μM against estradiol. This compound has applications in the study of various diseases, including liver conditions like NAFLD and NASH, metabolic and cardiovascular disorders, as well as drug-induced liver injury (DILI) [1]. |
| 分子量 | 475.71 |
| 分子式 | C21H13Cl3N4O3 |
| CAS No. | 2770247-34-0 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容